Showing results (2241-2250 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 16, 2017
Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian CancersSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
The Oncologist|December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M MutationLauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
The Oncologist|December 16, 2017
Patient-Reported Comorbidity and Survival in Older Adults with CancerGrant R Williams, Allison M Deal, Jennifer L Lund, et al.
The Oncologist|May 13, 2022
Variable Genomic Landscapes of Advanced Melanomas with Heavy PigmentationRichard S P Huang, Julie Y Tse, Lukas Harries, et al.
The Oncologist|July 17, 2021
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation RecipientsAnnabelle J Anandappa, Gabriela S Hobbs, Bimalangshu R Dey, et al.
The Oncologist|May 22, 2022
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain MetastasesRichard S P Huang, Lukas Harries, Brennan Decker, et al.
The Oncologist|May 23, 2022
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 PandemicStefania Napolitano, Vincenza Caputo, Anna Ventriglia, et al.
The Oncologist|May 10, 2022
Association Between Lifestyle Changes, Mammographic Breast Density, and Breast CancerSara P Lester, Aparna S Kaur, Suneela Vegunta
The Oncologist|May 10, 2022
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland CancersXiuning Le, Christina Baik, Jessica Bauman, et al.
The Oncologist|June 30, 2021
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus PembrolizumabVicky Makker, Matthew H Taylor, Ana Oaknin, et al.
Pageof 571